Skip to main content
. 2022 Aug 1;276(5):868–874. doi: 10.1097/SLA.0000000000005637

FIGURE 2.

FIGURE 2

Recurrence curves of transplanted liver cancer patients at 5 years (60 months), according to HepatoPredict Class I+II (blue lines) versus Milan or UCSF Criteria (gray lines, left and right columns, respectively). Cumulative recurrence curves for the entire population of transplanted patients compared with Milan (A) and UCSF (B) criteria, for the subpopulations of patients originally classified outside Milan (C) and UCSF (D) criteria, and for the subpopulations of patients originally classified within (E) Milan and (F) UCSF criteria.